Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Effects on Language Processing
NCT05272397Completed
- Sponsor
- Donders Centre for Cognitive Neuroimaging
- Start
- Nov 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Donders Centre for Cognitive Neuroimaging. Primary endpoints: Language Task Event-Related Potential (P600) and Language Task Alpha Power. Started Nov 2019; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05272397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05272397.